Institute of Pathology, University Hospital and University of Lausanne, Lausanne, Switzerland.
Endocr Pathol. 2021 Jun;32(2):245-257. doi: 10.1007/s12022-021-09676-z. Epub 2021 Mar 31.
The growth in knowledge of the pathogenesis, molecular background, and immunohistochemical profile of neuroendocrine neoplasms (NENs) has led not only to an increased awareness of these diseases but also to several changes of the nomenclature. In particular, the concept and terminology of high-grade (grade 3) NENs and mixed neoplasms have changed considerably over the last 20 years, creating some confusion among pathologists and clinicians. The aim of this review is to elucidate the diagnostic criteria, including the most important differential diagnoses of high-grade NENs and mixed neuroendocrine/non-neuroendocrine neoplasms (MiNENs). The role of the Ki67 labelling index and morphology, used to define grade 3 NENs of the digestive system and lungs, is also discussed. The evolution of the concepts and terminology of MiNENs is revised, including the most important differential diagnoses.
神经内分泌肿瘤(NENs)的发病机制、分子背景和免疫组织化学特征知识的增长不仅提高了人们对这些疾病的认识,还导致了命名法的一些变化。特别是,高级别(3 级)NENs 和混合性肿瘤的概念和术语在过去 20 年中发生了很大变化,给病理学家和临床医生造成了一些混淆。本文的目的是阐明高级别 NENs 和混合性神经内分泌/非神经内分泌肿瘤(MiNENs)的诊断标准,包括最重要的鉴别诊断。还讨论了用于定义消化系统和肺部 3 级 NENs 的 Ki67 标记指数和形态的作用。修订了 MiNENs 概念和术语的演变,包括最重要的鉴别诊断。